Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00440414 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Erlotinib (Tarceva)
DRUG: Pemetrexed (Alimta)

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]